Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: Heparin resistance revisited

Haematologica

Volumn 87, Issue 2, 2002, Pages 182-188

  Legnani, Cristina ^a   Preda, Luigi ^a   Palareti, Gualtiero ^a   Lunghi, Barbara ^a   Rossi, Edoardo ^a   Coccheri, Sergio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antithrombin III; Heparin; Prothrombin; Risk factor; Thrombophilia

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTITHROMBIN III; ECHIS VENOM; FIBRINOGEN; HEPARIN; PROTHROMBIN; SNAKE VENOM; UNCLASSIFIED DRUG;

ACTIVATED PROTHROMBIN HEPARIN INHIBITION TEST; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD CLOTTING TEST; CONTROLLED STUDY; DIAGNOSTIC ERROR; DRUG RESISTANCE; ENZYME BLOOD LEVEL; ENZYME INHIBITION; EVALUATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INTERNATIONAL STANDARD UNIT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; SEX DIFFERENCE; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTITHROMBIN III; BLOOD COAGULATION TESTS; CHILD; DRUG RESISTANCE; FEMALE; FIBRINOGEN; HEPARIN; HUMANS; MALE; MIDDLE AGED; PROTHROMBIN; RECURRENCE; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0036178684     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management
2. Inherited thrombophilia: Part 1
3. A new test for overall assessment of the activated factor II-antithrombin system
4. The anticoagulant effect of antithrombin/heparin complex. A new screening test to detect a thrombophilic tendency?
5. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria
6. Mutation in blood coagulation factor V associated with resistance to activated protein C
7. Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects
8. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
9. On estimating the relation between blood group and disease
10. The effect of platelet factor 4 (PF4) on assays of plasma heparin
11. Heparin binding properties of human histidine-rich glycoprotein: Mechanism and role in the neutralization of heparin in plasma
12. Heparin binding to plasma proteins, an important mechanism for heparin resistance
13. Heparin binding proteins - Contribution to heparin rebound after cardiopulmonary bypass
14. Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (enoxaparin) to plasma proteins